Articles by Katie Braswell

• 

  News
  HealthTree Foundation Pillar One: Personalized, Lifetime Support and Education
  Oct 02, 2023
• 

  News
  HealthTree Foundation Pillar One: Personalized, Lifetime Support and Education
  Oct 02, 2023
• 

  News
  HealthTree Foundation Pillar One: Personalized, Lifetime Support and Education
  Oct 02, 2023
• 

  News
  HealthTree Foundation Pillar One: Personalized, Lifetime Support and Education
  Oct 02, 2023
• 

  News
  HealthTree Foundation Pillar One: Personalized, Lifetime Support and Education
  Oct 01, 2023
• 

  News
  HealthTree Foundation Expands to Support Myelofibrosis Patients and Care Partners
  Sep 30, 2023
• 

  News
  HealthTree Foundation Expands to Support Lymphoma Patients and Care Partners
  Sep 30, 2023
• 

  News
  HealthTree Foundation Expands to Support DLBCL Patients and Care Partners
  Sep 30, 2023
• 

  News
  HealthTree Foundation Expands to Support Follicular Lymphoma Patients and Care Partners
  Sep 30, 2023
• 

  News
  HealthTree Foundation Expands to Support Hodgkin Lymphoma Patients and Care Partners
  Sep 29, 2023
• 

  News
  HealthTree Foundation Expands to Support CMML Patients and Care Partners
  Sep 29, 2023
• 

  News
  HealthTree 2.0: Expanding Our Reach to Support All Blood Cancers
  Sep 29, 2023
• 

  News
  HealthTree Foundation Expands to Support Non-Hodgkin's Lymphoma Patients and Care Partners
  Sep 29, 2023
• 

  News
  HealthTree 2.0: Expanding Our Reach to Support All Blood Cancers
  Sep 29, 2023
• 

  News
  HealthTree 2.0: Expanding Our Reach to Support All Blood Cancers
  Sep 28, 2023
• 

  News
  What Are Clinical Trials And Why Consider One?
  Sep 22, 2023
• 

  News
  The Innovation of AML Therapy: A Look From 2000 to the Present
  Sep 18, 2023
• 

  News
  The Innovation of AML Therapy: A Look From the 1970s to 2000
  Sep 15, 2023
• 

  News
  Breaking News: FDA Approves Quizartinib for FLT3 Positive Acute Myeloid Leukemia
  Jul 21, 2023
• 

  News
  ASCO 2023: Patient Preferences are Important in Determining AML Treatment
  Jul 13, 2023
• 

  News
  ASCO 2023: Early Testing of a Drug for P53 Mutated AML with Dr. Pardee
  Jul 10, 2023
• 

  News
  ASCO 2023: A Vaccine Therapy in Development for AML
  Jun 28, 2023
• 

  News
  ASCO 2023: Dr. Swoboda’s Work on Genetic Sequencing, Macrophages and BCL-2 Inhibitors for AML at Tampa General
  Jun 26, 2023
• 

  News
  Meet AML Coach, Steve Hodges
  Mar 29, 2023